(Reuters) -BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United States, the obesity drug developer said on Wednesday, in a sign of strong …
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f403245b484f8d8b8658f21e43c397&url=https%3A%2F%2Fwww.msn.com%2Fen-us%2Fmoney%2Fmarkets%2Fobesity-drug-developer-bioage-labs-aims-up-to-640-million-valuation-in-upsized-us-ipo%2Far-AA1rbnrX&c=16030240947875483050&mkt=en-us
Author :
Publish date : 2024-09-25 01:09:36
Copyright for syndicated content belongs to the linked Source.